NAVHC’s scientific committee is comprised of world class cardiology, surgical, and research experts. This committee works directly with NAVHC’s co-founder and medical director, Dr. Augusta Pelosi, the world’s only double board certified veterinary cardiologist and surgeon to ensure the most advanced science, surgical expertise, and research data are consistently reinvested into NAVHC’s portfolio of services. No other center or academic facility in the world offers this multifaceted approach to cardiology and surgery.
Setting the New Global Standard of Veterinary Cardiology and Open Heart Surgery
Did you know most of the advances within veterinary cardiology and surgery are created in partnership with human cardiologists and physicians? Only NAVHC offers unparalleled knowledge of the physiology of your pet, combined with the thought leadership of our world class scientific committee.
Your pet is your family at NAVHC. “We Fix Hearts.”
Jeffrey Zampi, MD
Interventional Cardiologist (Pediatric)
Director, Interventional Pediatric Cardiology
Assistant Professor, Division of Pediatric Cardiology
Jeffrey Zampi, MD, is the Director of Interventional Pediatric Cardiology at the University of Michigan Congenital Heart Center in Ann Arbor, Michigan. As an interventional pediatric cardiologist, he performs cardiac catheterization procedures on infants, children, and adults of all ages. Dr. Zampi is also an Intensivist in the Pediatric Cardiothoracic Intensive Care Unit, taking care of children and adults before and after heart surgery.
Dr. Zampi received his undergraduate degree in Biology with a minor in Neuroscience from Pennsylvania State University in 2002. After earning his medical doctorate from the University of Rochester School of Medicine and Dentistry in Rochester, NY in 2006, where he was inducted into the Gold Humanism Honor Society and Alpha Omega Alpha, Dr. Zampi completed his general pediatrics training at Children’s National Medical Center in Washington, DC in 2009. He then completed his pediatric cardiology fellowship at the University of Michigan Congenital Heart Center in Ann Arbor, MI in 2012 and stayed at the University of Michigan as a Clinical Lecturer for his interventional pediatric cardiology training. Dr. Zampi joined the faculty at the University of Michigan Congenital Heart Center in 2013.
Dr. Zampi’s clinical and academic interests focus on minimally-invasive procedures, especially in high-risk patients. These include hybrid procedures and fetal interventions, as well as transcatheter valve implantation in older children and adults. He leads several multicenter research projects to understand and improve the outcomes of patients with congenital heart disease.
Martin Bocks, MD
Director, Pediatric Interventional Cardiology, UH Rainbow Babies & Children’s Hospital
Associate Professor,Pediatric Cardiology, Case Western Reserve University School of Medicine
Dr. Bocks is the Director of Pediatric Interventional Cardiology at UH Rainbow Babies & Children’s Hospital and an Associate Professor of Pediatric Cardiology at Case Western Reserve University School of Medicine. After receiving his undergraduate degree at the University of Michigan with Honors in Biology, Dr. Bocks attended Wayne State University School of Medicine where he obtained his M.D. Dr. Bocks continued his medical training back at the University of Michigan and completed a 4 year residency in Internal Medicine-Pediatrics. He remained at the U of M for his Pediatric Cardiology Fellowship and also for his training in Pediatric Interventional Cardiology. Dr. Bocks was on faculty at the U of M from 2007 until coming to UH Rainbow Babies & Children’s Hospital in 2016. Dr. Bocks is board certified in Pediatric Cardiology and Adult Congenital Heart Disease. His clinical interests include transcatheter valve therapies and endovascular stenting in both children and adults with congenital heart defects. His research interests include pediatric medical device development with particular emphasis on bioresorbable technologies for cardiac catheterization procedures and wireless implantable pressure monitoring systems. Dr. Bocks has worked closely with the FDA and the Office of Orphan Products on his device projects. He has received funding from NIH via numerous Small Business Innovative Research (SBIR) grants (Phase I, II, IIB). He has performed GLP animal research at private CRO’s, written Investigational Device Exemption (IDE) and Humanitarian Use Device (HUD) designation applications, and is poised to start a multicenter clinical trial on a cardiovascular implantable device.
Edward Bove, MD
Cardiac Surgeon (Pediatric)
Chair, Department of Cardiac Surgery
Helen and Marvin Kirsh Professor of Surgery, 2005
Edward L. Bove, M.D. is a renowned pediatric cardiac surgeon and an internationally recognized expert on the treatment of complex congenital heart disease. He joined the faculty at the University of Michigan as director of Pediatric Cardiovascular Surgery and became Head of the Section of Cardiac Surgery in 1999. Dr. Bove was inaugurated as the first Helen and Marvin Kirsh Professor of Surgery in 2005 and Chair of the Department of Cardiac Surgery in 2012. Dr. Bove has received support for his research from the American Heart Association, the National Heart, Lung and Blood Institute, the National Institutes of Health, and the Leducq Foundation. He has held many named lectureships here and abroad and given hundreds of presentations on heart surgery around the world. He has served on numerous committees including the American Heart Association, the Society of Thoracic Surgeons, the American Association for Thoracic Surgery, and the American Board of Thoracic Surgery. Dr. Bove serves on a number of editorial boards, has published over 300 manuscripts, dozens of book chapters, and edited two books.
Richard G. Ohye, MD
Cardiac Surgeon (Pediatric)
Professor and Associate Chair, Department of Cardiac Surgery
Head, Section of Pediatric Cardiovascular Surgery
Co-Director, University of Michigan Congenital Heart Center
Richard G. Ohye is Professor and Associate Chair, Department of Cardiac Surgery, Head of the Section of Pediatric Cardiovascular Surgery and co-Director of the University of Michigan C.S. Mott Children’s Hospital Congenital Heart Center. After graduating from the Ohio State University Medical School, he stayed at Ohio State for his General Surgery residency, a transplantation immunology research fellowship and his Thoracic residency. Following a fellowship in Pediatric Cardiovascular Surgery at the University of Michigan in 1998, Dr. Ohye became the Director of Pediatric Cardiac Surgery at Albany Medical Center. In 2000, he returned to the University of Michigan as faculty in the Section of Pediatric Cardiovascular Surgery and Program Director of the Pediatric Cardiac Surgery Fellowship. In 2009, Dr. Ohye became the Head the Section of Pediatric Cardiovascular Surgery and co-Director of the Congenital Heart Center. Subsequently, Dr. Ohye assumed the role of Associate Chair for the Department of Cardiac Surgery in 2016.
Dr. Ohye’s major clinical interests are in complex congenital heart defect repair. His research interests are in clinical and translational research, and he is the Co-Founder of the Michigan Congenital Heart Outcomes Research and Discovery (M-CHORD) program. Dr. Ohye is the study chair of a 15-center randomized trial comparing techniques for the Norwood operation for hypoplastic left heart syndrome, the first multi-institutional prospective trial ever performed in congenital heart surgery. He has a strong interest in innovative device development for pediatric patients with cardiovascular and respiratory disease, and is currently involved with the development of several novel devices.
Augusta Pelosi, DVM
Cardiologist and Surgeon (Veterinary)
Medical Director, Cardiac Surgeon and Cardiologist
Co-Founder of North American Veterinary Heart Center
Steven F. Bolling, MD
Cardiac Surgeon (Adult)
Professor of Surgery, Department of Cardiac Surgery
Director, Myocellular Biology Laboratory
Director, Multidisciplinary Mitral Valve Clinic
Dr. Steven F. Bolling is a Professor of Surgery in the Department of Cardiac Surgery at the University of Michigan. Both his undergraduate and medical school education were at the University of Michigan. Following this, he trained in general and thoracic surgery at Johns Hopkins.
He joined the Cardiac Surgery facility at the University of Michigan in the mid 1980s and helped create and direct the multidisciplinary mitral valve clinic. He is an active participant in all the major cardiac surgical societies and a recognized expert in mitral valve surgery. He is the author of over 350 peer-reviewed publications and holds numerous grants, including NIH, AHA, and industry grants.
He is the Director of the Myocellular Biology Laboratory. His research is in the molecular biology of heart failure, with a special interest in myocyte signal transduction. He is also the Director of the Multidisciplinary Mitral Valve Clinic.
Arthur H. Katz, MD
Cardiac Surgeon (Adult)
Honor Medical Society, Member
The Society of Thoracic Surgeons, Member
Arthur H. Katz is a board certified adult cardiac surgeon practicing in Palm Beach County Florida since 1994. Dr. Katz completed his undergraduate education at SUNY Stony Brook and Medical School at New York Medical College, Valhalla, NY where he graduated with honors (Alpha Omega Alpha). He completed his residency in General Surgery and Fellowship in Cardiac Surgery in 1992 at NYU Medical Center in New York City.
Dr. Katz is a member of AOA, the Honor Medical Society and The Society of Thoracic Surgeons. He helped establish an open heart program at Boca Regional Hospital, Boca Raton, FL. His forte includes reconstructive surgery of the mitral valve, surgery of the aortic and tricuspid valves, off pump (OPCAB, beating heart) bypass surgery, ablative surgery for artrial fibrillation, left ventricular reconstruction, and surgery of the aorta.
Saurabh Sanon, MD
Interventional Cardiologist (Adult)
Richard W. Bianco
Cardiac Surgeon (Adult)
Director of Experimental Surgery and Professor of Surgery, University of Minnesota
Richard W. Bianco is Director of Experimental Surgery and Professor of Surgery at the University of Minnesota. He has more than 40 years of experience in the management of Experimental Surgical projects and has authored numerous refereed journal articles and book chapters on the topics of animal model development and the assessment of new or modified medical devices with a major emphasis in the area of cardiovascular prostheses. His particular research interest is in the development of accurate and humane animal models that predict safe clinical performance and efficacy Experimental Surgery at the University of Minnesota is the premier GLP facility in the world and is recognized both domestically and internationally as the leading facility conducting pre-clinical safety evaluations.
Professor Bianco has served on various committees of the International Standards Organization (ISO) and is currently is expert member of several working groups and sub-committees including Animal Welfare, Cardiac Valves, and Vascular Grafts (Co-Chair).
Finally, Professor Bianco has been a national leader in promoting the humane use of animals in medical research and has served on the Boards of both the National Organization for Biomedical Research (NABR, Americans for Medical Progress (AMP), and the National Marine Mammal Advisory Board).